Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Hutchinson–Gilford progeria syndrome (HGPS) is an extremely rare, fatal, segmental premature aging syndrome caused by a mutation in LMNA that produces the farnesylated aberrant lamin A protein, progerin. This multisystem disorder causes failure to thrive and accelerated atherosclerosis leading to early death. Farnesyltransferase inhibitors have ameliorated disease phenotypes in preclinical studies. Twenty-five patients with HGPS received the farnesyltransferase inhibitor lonafarnib for a minimum of 2 y. Primary outcome success was predefined as a 50% increase over pretherapy in estimated annual rate of weight gain, or change from pretherapy weight loss to statistically significant on-study weight gain. Nine patients experienced a ≥50% increase, six experienced a ≥50% decrease, and 10 remained stable with respect to rate of weight gain. Secondary outcomes included decreases in arterial pulse wave velocity and carotid artery echodensity and increases in skeletal rigidity and sensorineural hearing within patient subgroups. All patients improved in one or more of these outcomes. Results from this clinical treatment trial for children with HGPS provide preliminary evidence that lonafarnib may improve vascular stiffness, bone structure, and audiological status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predicting basal metabolic rate, new standards and review of previous work.
Wn, S. (1985) · PubMed · Cited by 2,958
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003) · Nature · doi:10.1038/nature01629 · Cited by 1,990
Self-citationCruickshank, K., Riste, L., Anderson, S. G., Wright, J. S., Dunn, G., & Gosling, R. G. (2002) · Circulation · doi:10.1161/01.cir.0000033824.02722.f7 · Cited by 1,531
Lamin a truncation in Hutchinson-Gilford progeria
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. (2003) · Science · doi:10.1126/science.1084125 · Cited by 1,346
Lamin A-dependent nuclear defects in human aging
Scaffidi, P., & Misteli, T. (2006) · Science · doi:10.1126/science.1127168 · Cited by 1,125
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. E., Gordon, L. B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402943101 · Cited by 1,103 · cited 1×
“Persistent farnesylation causes progerin accumulation in the inner nuclear membrane and is at least partly responsible for the HGPS phenotype (5).”
BackgroundSelf-citationClinical applications of arterial stiffness; definitions and reference values
O'Rourke, M. F., Staessen, J. A., Vlachopoulos, C., Duprez, D., & Plante, G. E. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02319-6 · Cited by 1,100
Phenotype and Course of Hutchinson–Gilford Progeria Syndrome
Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C. M., Perry, M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706898 · Cited by 743
Self-citationNuclear Lamins: Laminopathies and Their Role in Premature Ageing
Broers, J. L. V., Ramaekers, F. C. S., Bonne, G., Yaou, R. B., & Hutchison, C. J. (2006) · Physiological Reviews · doi:10.1152/physrev.00047.2005 · Cited by 578
Hutchinson–Gilford progeria syndrome: Review of the phenotype
Hennekam, R. C. M. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31346 · Cited by 575
Olive, M., Harten, I., Mitchell, R., Beers, J. K., Djabali, K., Cao, K., Erdos, M. R., Blair, C., Funke, B., Smoot, L., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.209460 · Cited by 433
Self-citationRedheuil, A., Yu, W.-C., Wu, C. O., Mousseaux, E., de Cesare, A., Yan, R., Kachenoura, N., Bluemke, D., & Lima, J. A. C. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.141275 · Cited by 386
McClintock, D., Ratner, D., Lokuge, M., Owens, D. M., Gordon, L. B., Collins, F. S., & Djabali, K. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001269 · Cited by 367
Self-citationA Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria
Fong, L. G., Frost, D., Meta, M., Qiao, X., Yang, S. H., Coffinier, C., & Young, S. G. (2006) · Science · doi:10.1126/science.1124875 · Cited by 316
Reference Values of Pulse Wave Velocity in Healthy Children and Teenagers
Reusz, G. S., Cseprekal, O., Temmar, M., Kis, E., Cherif, A. B., Thaleb, A., Fekete, A., Szabó, A. J., Benetos, A., & Salvi, P. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.152686 · Cited by 302
Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors
Basso, A. D., Kirschmeier, P., & Bishop, W. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500012-jlr200 · Cited by 297
Self-citationVarga, R., Eriksson, M., Erdos, M. R., Olive, M., Harten, I., Kolodgie, F., Capell, B. C., Cheng, J., Faddah, D., Perkins, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600012103 · Cited by 296
Self-citationJames, G. L., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6221 · Cited by 290
Cao, K., Blair, C. D., Faddah, D. A., Kieckhaefer, J. E., Olive, M., Erdos, M. R., Nabel, E. G., & Collins, F. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43578 · Cited by 284
Yang, S. H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28968 · Cited by 263
Gordon, C. M., Grace, E., Emans, S. J., Feldman, H. A., Goodman, E., Becker, K. A., Rosen, C. J., Gundberg, C. M., & LeBoff, M. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020545 · Cited by 235
Self-citationCapell, B. C., Olive, M., Erdos, M. R., Cao, K., Faddah, D. A., Tavarez, U. L., Conneely, K. N., Qu, X., San, H., Ganesh, S. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807840105 · Cited by 214
McClintock, D., Gordon, L. B., & Djabali, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511133103 · Cited by 198
Self-citationFarnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors
Rusiñol, A. E., & Sinensky, M. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.03156 · Cited by 174
Mechanisms of Premature Vascular Aging in Children With Hutchinson-Gilford Progeria Syndrome
Gerhard-Herman, M., Smoot, L. B., Wake, N., Kieran, M. W., Kleinman, M. E., Miller, D. T., Schwartzman, A., Giobbie-Hurder, A., Neuberg, D., & Gordon, L. B. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180919 · Cited by 155
Self-citationDisease Progression in Hutchinson-Gilford Progeria Syndrome: Impact on Growth and Development
Gordon, L. B., McCarten, K. M., Giobbie-Hurder, A., Machan, J. T., Campbell, S. E., Berns, S. D., & Kieran, M. W. (2007) · Pediatrics · doi:10.1542/peds.2007-1357 · Cited by 132
Self-citationSmooth muscle cell depletion and collagen types in progeric arteries
Stehbens, W. E., Delahunt, B., Shozawa, T., & Gilbert‐Barness, E. (2001) · Cardiovascular Pathology · doi:10.1016/s1054-8807(01)00069-2 · Cited by 130
Clinical and genetic heterogeneity in laminopathies
Bertrand, A., Chikhaoui, K., Yaou, R. B., & Bonne, G. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110670 · Cited by 114
Wren, T. A. L., Liu, X., Pitukcheewanont, P., & Gilsanz, V. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1351 · Cited by 109
Kieran, M. W., Gordon, L., & Kleinman, M. (2007) · Pediatrics · doi:10.1542/peds.2007-1356 · Cited by 99
Self-citationMethods for measurement of pediatric bone
Binkley, T. L., Berry, R., & SPECKER, B. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9073-5 · Cited by 92
Hutchinson-gilford progeria is a skeletal dysplasia
Gordon, C. M., Gordon, L. B., Snyder, B. D., Nazarian, A., Quinn, N., Huh, S., Giobbie-Hurder, A., Neuberg, D., Cleveland, R., Kleinman, M., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.392 · Cited by 88
Self-citationLind, L., Andersson, J., Rönn, M., & Gustavsson, T. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.029 · Cited by 76
Pulse Wave Velocity in End-Stage Renal Disease: Influence of Age and Body Dimensions
Kis, É., Cseprekál, O., Horváth, Z., Katona, G., Fekete, B., Hrapka, E., Szabó, A., Szabo, A. J., Fekete, A., & Reusz, G. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31815b47ff · Cited by 76
Kieran, M. W., Packer, R. J., Onar, A., Blaney, S. M., Phillips∥, P. C., Pollack, I. F., Geyer, J. R., Gururangan, S., Banerjee, A., Goldman, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4243 · Cited by 65
Self-citationOn the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
Feldman, E. J., Cortes, J. E., DeAngelo, D. J., Holyoake, T. L., Simonsson, B., O'Brien, S. G., Reiffers, J. J., Turner, A. R., Roboz, G. J., Lipton, J. H., et al. (2008) · Leukemia · doi:10.1038/leu.2008.156 · Cited by 65
Self-citationThe cell nucleus and aging: tantalizing clues and hopeful promises
Scaffidi, P., Gordon, L., & Misteli, T. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030395 · Cited by 50
Self-citationHutchinson‐Gilford progeria syndrome: oral and craniofacial phenotypes
Domingo, D., Trujillo, M., Merideth, M., Gordon, L. B., Wu, T., Introne, W. J., Gahl, W. A., & Hart, T. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2009.01521.x · Cited by 34
Self-citation
Cited by
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Fighting against Skin Aging: The Way from Bench to Bedside
Zhang, S., & Duan, E. (2018) · Cell Transplantation · doi:10.1177/0963689717725755 · Cited by 739
Post-translational modifications of intermediate filament proteins: mechanisms and functions
Snider, N. T., & Omary, M. B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3753 · Cited by 524
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
Jiang, H., Zhang, X., Chen, X., Aramsangtienchai, P., Tong, Z., & Lin, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00750 · Cited by 500
In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice
Koblan, L. W., Erdos, M. R., Wilson, C., Cabral, W. A., Levy, J. M., Xiong, Z.-M., Tavarez, U. L., Davison, L. M., Gete, Y. G., Mao, X., et al. (2021) · Nature · doi:10.1038/s41586-020-03086-7 · Cited by 483
Self-citation
Metadata
- Authors
- Gordon, L. B., Kleinman, M. E., Miller, D. T., Neuberg, D. S., Giobbie-Hurder, A., Gerhard-Herman, M., Smoot, L. B., Gordon, C. M., Cleveland, R., Snyder, B. D., Fligor, B., Bishop, W. R., Statkevich, P., Regen, A., Sonis, A., Riley, S., Ploski, C., Correia, A., Quinn, N., Ullrich, N. J., Nazarian, A., Liang, M. G., Huh, S. Y., Schwartzman, A., & Kieran, M. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-09-24
- Volume
- 109
- Issue
- 41
- Pages
- 16666-16671
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2016268789
- Cited by
- 375
- References
- 38
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.